Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
Hricik
D E
DE
Department of Medicine, Case Western Reserve University of Medicine, Cleveland, Ohio.
Zarconi
J
J
Schulak
J A
JA
D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D000911:Antibodies, Monoclonal / Q000032:analysis / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000627:therapeutic use*; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000627:therapeutic use; D011897:Random Allocation
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine; D008775:Methylprednisolone